IRIS PubliCatt

Basso, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.804
EU - Europa 1.448
AS - Asia 429
AF - Africa 21
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.709
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.799
DE - Germania 594
SE - Svezia 292
CN - Cina 189
IT - Italia 181
SG - Singapore 124
UA - Ucraina 67
IE - Irlanda 59
FR - Francia 46
GB - Regno Unito 46
FI - Finlandia 45
ID - Indonesia 39
RU - Federazione Russa 37
IN - India 28
CI - Costa d'Avorio 21
PL - Polonia 21
BE - Belgio 20
TR - Turchia 18
IR - Iran 13
NL - Olanda 7
CZ - Repubblica Ceca 6
GR - Grecia 6
HK - Hong Kong 6
AT - Austria 4
CA - Canada 4
RO - Romania 4
JP - Giappone 3
KR - Corea 3
LT - Lituania 3
AU - Australia 2
CH - Svizzera 2
EU - Europa 2
NO - Norvegia 2
TH - Thailandia 2
BN - Brunei Darussalam 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 3.709
Salva come PNG Salva come JPEG
Città #
Ashburn 558
Chandler 320
Singapore 96
Dublin 58
Ann Arbor 52
San Mateo 52
Wilmington 52
Cattolica 45
New York 43
Jacksonville 42
Jakarta 39
Nanjing 39
Nürnberg 33
Boston 29
Dearborn 29
Helsinki 28
Woodbridge 28
Rome 27
Fairfield 26
Princeton 25
Chicago 24
Moscow 24
Abidjan 21
Nanchang 21
Marseille 20
Warsaw 20
Brussels 19
Milan 19
Redwood City 19
Izmir 17
Boardman 16
Houston 15
Munich 15
Beijing 14
Redmond 14
Bremen 13
Seattle 13
Shanghai 13
Augusta 12
Falls Church 12
Hangzhou 12
Los Angeles 12
Lawrence 10
Leawood 10
Changsha 9
Hebei 9
Mountain View 9
Norwalk 9
Cambridge 8
Santa Clara 7
Zhengzhou 7
Bari 5
Fremont 5
Kunming 5
Washington 5
Andover 4
Athens 4
Brno 4
Guangzhou 4
Jiaxing 4
Kish 4
Lanzhou 4
London 4
Plainfield 4
Shenyang 4
Vienna 4
Amsterdam 3
Detroit 3
Jinan 3
Miami 3
Northbrook 3
Piacenza 3
San Diego 3
Toronto 3
University Park 3
Bangkok 2
Birmingham 2
Changchun 2
Falkenstein 2
Florence 2
Frankfurt am Main 2
Hong Kong 2
Hounslow 2
Köln 2
Legnano 2
Naples 2
Ningbo 2
Olomouc 2
Oslo 2
Qingdao 2
Simi Valley 2
Taiyuan 2
Tianjin 2
Trento 2
Zanjan 2
Zurich 2
Acton 1
Afragola 1
Ardabil 1
Auburn Hills 1
Totale 2.201
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 509
A phase II study of sunitinib in advanced hepatocellular carcinoma 206
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 200
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 182
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 159
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 137
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 128
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 126
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 124
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 107
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 104
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 103
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 99
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 93
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 83
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 83
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 82
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 78
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 76
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 73
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 73
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 66
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 66
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 63
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 63
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 62
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 61
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 60
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 58
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 56
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 56
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 51
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 49
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 41
New life for retrospective study in the precision oncology era 33
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 28
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 25
Targeted therapy in advanced gastric carcinoma: The future is beginning 25
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 22
Totale 3.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 0 36 20 62 16 19 25 80 36
2020/2021267 8 37 38 16 30 12 26 4 25 27 38 6
2021/2022451 37 16 12 64 27 11 7 68 17 37 60 95
2022/2023873 123 118 70 160 30 98 48 74 74 25 32 21
2023/2024855 19 89 28 14 11 71 234 263 2 16 38 70
2024/2025222 15 39 70 37 61 0 0 0 0 0 0 0
Totale 3.780